PATENT CLAIM ANALYSIS

Application Number: 15903785
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "171000"]

Abstract:
Topical pharmaceutical compositions comprise a combination of a corticosteroid and a retinoid; and methods for treating psoriasis with same. In one embodiment, the corticosteroid comprises halobetasol propionate, and the retinoid comprises tazarotene.

Claim (Index 1):
A method of treating psoriasis, the method comprising topically applying a pharmaceutical composition to an affected area of a body of a subject suffering from psoriasis; wherein the composition comprises:\n (a) halobetasol propionate at a concentration of 0.01 percent by weight of the composition; (b) tazarotene at a concentration of 0.045 percent by weight of the composition; and (c) an aqueous dermatologically acceptable carrier comprising carbomer copolymer type B, carbomer homopolymer type A, and a liquid oil comprising diethyl sebacate and light mineral oil; and wherein said applying is carried out one or more times per day for a period of time sufficient to treat such psoriasis.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.37037
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15173961', '15621325', '15209716', '14463985', '13921833']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7019314035441007
- 35 USC 102 Novelty (BERT): 0.5438345057545992
- Combined Prediction Score: 0.6861217137651505
- Mean Citation Score: 221.16387000000003
- Max Citation Score: 374.73453
- Similarity Product: 317.1751359386945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test